Don’t be surprised if it becomes more and more difficult to find generic versions of prescription drugs. Drug manufacturers have a new trick up their sleeves known as Pay to Delay. The generic drug maker gets paid off to delay offering their version of the medicine.
Over the last few years, drug-makers have embraced a startlingly simple tactic for fending off competition from generic brands: paying them off. In a nutshell, the company that holds the patent on a profitable drug strikes a deal with the maker of the cheaper generic brand: you hold off on marketing your generic for several years, and in return, we'll give you a share of our profits on the drug.
When it comes to affordable health care, remember who is friend and who is foe.
